3 Firms Steer New Takeda, Frazier Biopharma Venture
Pharmaceutical giant Takeda on Wednesday said it is teaming up with Frazier Healthcare Partners to create a biopharmaceutical firm focused on gastrointestinal issues, with the Gunderson Dettmer-led venture capital firm leading...To view the full article, register now.
Already a subscriber? Click here to view full article